Newsletter

Infectious Diseases

Most popular
A nurse wearing a mask holding a syringe containing vaccine.

Inovio’s Vaccine Demonstrates Robust Immunogenicity in Animal Models

Illustration of a pangolin from "On The Genesis of Species" by St. George Mivart.

Coronavirus Source Potentially Traced to Malayan Pangolins

A scientist holding a needle containing a vaccine, such as that currently being evaluated in human trials for the prevention of COVID-19 by Inovio Pharmaceuticals.

Inovio Pharmaceuticals Announces Human Trials of Coronavirus Vaccine

A scientist reviewing the contents of a test tube. The coronavirus vaccine under development by Novavax could lead to the end of the pandemic. Widespread use of the vaccine would occur after successful phase 3 clinical trials.

Novavax News: Progress Towards Phase 3 Trials of Coronavirus Vaccine

Novel Vaccine Strategy Induces Potent anti-HCV Immune Response

Left: This scanning electron microscope image shows SARS-CoV-2 (round magenta objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Source: NIAID-RML. Right: Dr. Gang Chen, MD, PhD, the senior author of a recent case report published in the American Journal of Transplantation that outlined the recovery of an immunosuppressed transplant recipient from COVID-19.

Immunosuppressed Transplant Recipient Recovers from COVID-19

Blood samples resting on a surface.

NantKWest & Be The Match to Advance COVID-19 Therapy BM-AlloMSC

Pills resting on a surface as a reference to the drug remdesivir by Gilead Sciences. The medication is currently being evaluated for the treatment of COVID-19 in phase 3 clinical trials.

Gilead Completes Phase 3 Trial of Remdesivir for Treatment of COVID-19

Study Evaluating Coronavirus Symptoms Demonstrates Pneumonia and Severe Respiratory Complications

A person holding tubes of blood.

ARCA Biopharma to Develop Tissue Factor Inhibitor as COVID-19 Therapy

1234Page 1 of 4

Contact

Connect

Follow Us

ImmunoFrontiers LLC © 2019-2022. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

error: Content is protected.